PMID- 26888462 OWN - NLM STAT- MEDLINE DCOM- 20170719 LR - 20220318 IS - 1873-734X (Electronic) IS - 1010-7940 (Linking) VI - 50 IP - 2 DP - 2016 Aug TI - Meta-analysis of concomitant mitral valve repair and coronary artery bypass surgery versus isolated coronary artery bypass surgery in patients with moderate ischaemic mitral regurgitation. PG - 212-22 LID - 10.1093/ejcts/ezw022 [doi] AB - Ischaemic mitral regurgitation (IMR) is a complication of coronary artery disease with normal chordal and leaflet morphology. Controversy surrounds the issue of appropriate surgical management of moderate IMR. With the present meta-analysis, we aimed to determine whether the addition of mitral valve (MV) repair to coronary artery bypass grafting (CABG) improved clinical outcome over CABG alone in patients with moderate IMR. Databases were searched for studies reporting on clinical outcomes after CABG and MV repair or CABG alone for moderate IMR. Clinical end-points were operative mortality, survival, New York Heart Association (NYHA) class >/=2 and MR grade >/=2 at last follow-up. A total of five observational and four randomized controlled trials (RCTs) were identified. The mean follow-up was 2.7 years. An analysis of all studies revealed increased operative risk in the concomitant CABG and MV repair group risk ratio [RR] 2.02 [95% confidence interval (CI) 1.15, 3.56], P = 0.01, I(2) = 0%. However, an analysis of RCTs only showed that the operative risk was equivalent [RR 1.05 (95% CI 0.34, 3.30), P = 0.93, I(2) = 0%]. Pooled hazard ratio (HR) on survival did not favour either procedure [all studies: HR 1.08 (95% CI 0.77, 1.50), P = 0.66, I(2) = 0%; RCTs only: HR 0.89 (95% CI 0.47, 1.70), P = 0.73, I(2) = 0%]. The incidence of exercise intolerance quantified as NYHA class >/=2 was similar between groups (all studies: RR 0.72 (95% CI 0.42, 1.24), P = 0.24, I(2) = 77%; RCTs only: RR 0.61 (95% CI 0.24, 1.55), P = 0.30, I(2) = 83%]. Risk of residual MR grade >/=2 was higher in the CABG only group [all studies: RR 0.30 (95% CI 0.16, 0.60), P < 0.001, I(2) = 83%; RCTs only: RR 0.20 (95% CI 0.04, 0.90), P = 0.04, I(2) = 72%]. There is neither increased operative mortality nor survival benefit associated with concomitant CABG and MV repair for IMR of moderate degree over CABG alone. Further studies with long-term follow-up data and sub-group analyses of current data are needed to define a subset of patients whose survival and functional status may improve with the concomitant MV repair. CI - (c) The Author 2016. Published by Oxford University Press on behalf of the European Association for Cardio-Thoracic Surgery. All rights reserved. FAU - Kopjar, Tomislav AU - Kopjar T AD - University of Zagreb School of Medicine, Department of Cardiac Surgery, University Hospital Centre Zagreb, Zagreb, Croatia tkopjar@gmail.com. FAU - Gasparovic, Hrvoje AU - Gasparovic H AD - University of Zagreb School of Medicine, Department of Cardiac Surgery, University Hospital Centre Zagreb, Zagreb, Croatia. FAU - Mestres, Carlos A AU - Mestres CA AD - Heart and Vascular Institute, Cleveland Clinic Abu Dhabi, Abu Dhabi, United Arab Emirates. FAU - Milicic, Davor AU - Milicic D AD - University of Zagreb School of Medicine, Department of Cardiovascular Diseases, University Hospital Centre Zagreb, Zagreb, Croatia. FAU - Biocina, Bojan AU - Biocina B AD - University of Zagreb School of Medicine, Department of Cardiac Surgery, University Hospital Centre Zagreb, Zagreb, Croatia. LA - eng PT - Journal Article PT - Meta-Analysis PT - Review DEP - 20160216 PL - Germany TA - Eur J Cardiothorac Surg JT - European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery JID - 8804069 SB - IM MH - Coronary Artery Bypass/*methods MH - Coronary Artery Disease/complications/*surgery MH - Heart Valve Prosthesis Implantation/*methods MH - Humans MH - Mitral Valve/*surgery MH - Mitral Valve Insufficiency/*surgery MH - Myocardial Ischemia/complications/*surgery OTO - NOTNLM OT - Coronary bypass OT - Ischaemic mitral regurgitation OT - Meta-analysis OT - Mitral valve repair OT - Outcomes EDAT- 2016/02/19 06:00 MHDA- 2017/07/20 06:00 CRDT- 2016/02/19 06:00 PHST- 2015/09/08 00:00 [received] PHST- 2016/01/11 00:00 [accepted] PHST- 2016/02/19 06:00 [entrez] PHST- 2016/02/19 06:00 [pubmed] PHST- 2017/07/20 06:00 [medline] AID - ezw022 [pii] AID - 10.1093/ejcts/ezw022 [doi] PST - ppublish SO - Eur J Cardiothorac Surg. 2016 Aug;50(2):212-22. doi: 10.1093/ejcts/ezw022. Epub 2016 Feb 16.